These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30269181)

  • 21. Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1993 Sep; 32(3):431-44. PubMed ID: 8262865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.
    Kim SH; Kim KH; Kim HB; Kim NJ; Kim EC; Oh MD; Choe KW
    Antimicrob Agents Chemother; 2008 Jan; 52(1):192-7. PubMed ID: 17984229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-ESBL producing Klebsiella pneumoniae.
    Burgess DS; Hall RG
    Diagn Microbiol Infect Dis; 2004 May; 49(1):41-6. PubMed ID: 15135499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Ceftaroline against Methicillin-Susceptible Staphylococcus aureus Exhibiting the Cefazolin High-Inoculum Effect in a Rat Model of Endocarditis.
    Singh KV; Tran TT; Nannini EC; Tam VH; Arias CA; Murray BE
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
    Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
    BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of ertapenem, ciprofloxacin, ceftriaxone, piperacillin-tazobactam, and ampicillin-sulbactam against 12 common clinical isolates of community-acquired bacteremia.
    Hwang KP; Tang YF; Shen YH
    J Microbiol Immunol Infect; 2009 Oct; 42(5):433-8. PubMed ID: 20182674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.
    Pericàs JM; Messina JA; Garcia-de-la-Mària C; Park L; Sharma-Kuinkel BK; Marco F; Wray D; Kanafani ZA; Carugati M; Durante-Mangoni E; Tattevin P; Chu VH; Moreno A; Fowler VG; Miró JM;
    Clin Microbiol Infect; 2017 Aug; 23(8):544-549. PubMed ID: 28159672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of prophylaxis with beta-lactams and beta-lactam-beta-lactamase inhibitor combinations against wound infection by methicillin-resistant and borderline-susceptible Staphylococcus aureus in a guinea pig model.
    Kernodle DS; Kaiser AB
    Antimicrob Agents Chemother; 1993 Apr; 37(4):702-7. PubMed ID: 8494364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penicillin-susceptible Staphylococcus aureus bacteremia: Epidemiological and clinical relevance. Possible therapeutic implications.
    Aspiroz C; Mama OM; Martínez-Álvarez RM; Ruiz-Ripa L; Ceballos S; Torres C
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Nov; 38(9):434-437. PubMed ID: 31955893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Susceptibility of Clinical Isolates to Ceftriaxone Alone and Ceftriaxone in Combination With Sulbactam or Tazobactam: A Comparative Study of Broad-Spectrum β-Lactam Antibiotics in India.
    Sanghavi S; Ghoshal U; Poddar S; Satpute M; Sahu C; Pawar D; Sharma A; Vaidya PH
    Cureus; 2023 Sep; 15(9):e46014. PubMed ID: 37900428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus.
    Jones ME
    Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
    Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
    Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
    Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].
    López-Hernández S; Alarcón T; Delgado T; de Las Cuevas MC; López-Brea M
    Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum beta-lactamase-producing and extended-spectrum beta-lactamase-non-producing Escherichia coli isolates.
    López-Cerero L; Picón E; Morillo C; Hernández JR; Docobo F; Pachón J; Rodríguez-Baño J; Pascual A
    Clin Microbiol Infect; 2010 Feb; 16(2):132-6. PubMed ID: 19614715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. β-Lactam Therapy for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Comparative Review of Cefazolin versus Antistaphylococcal Penicillins.
    Li J; Echevarria KL; Traugott KA
    Pharmacotherapy; 2017 Mar; 37(3):346-360. PubMed ID: 28035690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK; Mendes RE; Silbert S; Bolsoni AP; Sader HS
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of a cefazolin inoculum effect associated with blaZ gene types, and clinical outcomes among methicillin-susceptible Staphylococcus aureus blood isolates of patients with infective endocarditis.
    Bourreau A; Le Mabecque V; Broquet A; Caillon J
    Infect Dis Now; 2023 Feb; 53(1):104626. PubMed ID: 36184048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A class A β-lactamase produced by borderline oxacillin-resistant Staphylococcus aureus hydrolyses oxacillin.
    Nomura R; Nakaminami H; Takasao K; Muramatsu S; Kato Y; Wajima T; Noguchi N
    J Glob Antimicrob Resist; 2020 Sep; 22():244-247. PubMed ID: 32200127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.